-
TCRR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Tcr2 Therapeutics (TCRR)
Company Profile
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 15.60 mm | 15.60 mm | 15.60 mm | 15.60 mm | 15.60 mm | 15.60 mm |
Cash burn (monthly) | 6.10 mm | 4.97 mm | 13.84 mm | 13.82 mm | 13.34 mm | 9.19 mm |
Cash used (since last report) | 140.78 mm | 114.77 mm | 319.30 mm | 318.87 mm | 307.79 mm | 212.20 mm |
Cash remaining | -125.18 mm | -99.17 mm | -303.71 mm | -303.27 mm | -292.19 mm | -196.60 mm |
Runway (months of cash) | -20.5 | -19.9 | -22.0 | -21.9 | -21.9 | -21.4 |
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 39.63 mm |
Total shares | 4.02 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Tang Capital Partners | 2.74 mm | $0.00 |
Upnorth Investment | 1.28 mm | $39.63 mm |